<DOC>
	<DOCNO>NCT00573144</DOCNO>
	<brief_summary>The purpose study determine efficacy intravenous human beta natriuretic peptide ( BNP , Nesiritide ) compare placebo prevent adverse post acute myocardial infarction leave ventricular remodeling .</brief_summary>
	<brief_title>Nesiritide Therapy Preserve Function Left Ventricle After Myocardial Infarction</brief_title>
	<detailed_description>Post acute myocardial infarction ( AMI ) leave ventricular ( LV ) remodel begin within hour acute event permanent consequence . Previous study demonstrate LV remodel one major determinant long-term survival post AMI . Recent study report cardiac natriuretic peptide , atrial natriuretic peptide ( ANP ) BNP direct anti-fibrotic anti-proliferative effect myocardium . More importantly , report acute phase AMI , secretion cardiac natriuretic peptide may insufficient relative chronic phase . Therefore , augmentation cardiac natriuretic peptide system , exogenous administration exogenous peptide may prevent post AMI LV remodel cardioprotective effect . The objective study determine efficacy IV human BNP ( Nesiritide ) compare placebo prevent adverse post AMI LV remodel . This randomized double blind placebo control study determine efficacy 72 hour IV BNP 0.006Âµg/Kg/min compare placebo patient anterior ST-elevation myocardial infarction successful revascularization . The study population include 60 patient admit Cardiac Care Unit first anterior AMI successful reperfusion therapy ( TIMI grade 3 flow ) within 24 hour onset chest pain document coronary angiography .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Inclusion criterion : Patients acute ST elevation myocardial infarction &gt; = 2 mm ST elevation one combination anterior lead , successful revascularization ( TIMI grade 3 flow ) lesion within 24 hour symptom consent within 24 hour procedure . Exclusion criterion : Cardiogenic shock hypotension , Systolic BP &lt; 90 mmHg overt Congestive Heart Failure ( CHF ) Previous history MI ( Myocardial Infarction ) Previous ECG suggest previous MI Known Ejection Fraction ( EF ) &lt; 30 % Atrial fibrillation Previously know significant valvular disease ( Grade III , IV ) , cardiomyopathy congenital heart disease . Hemoglobin &lt; 10 mg/dL Pregnant women/nursing mother Participants still menstruate surgically sterilize must negative pregnancy test prior participate study . Unable undergo cardiac MRI ( Magnetic Resonance Imaging ) . Contraindications MRI include pacemaker defibrillator , pregnant woman , atrial fibrillation arrhythmia , cerebral aneurysm clip severe claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>